Literature DB >> 10392628

Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.

M C Jenkins1, C O'Brien, J Trout, A Guidry, R Fayer.   

Abstract

Preparturient cows were immunized three times over a six-week period with recombinant plasmid DNA encoding the Cryptosporidium parvum CP15/60 antigen by injecting the DNA in the mammary gland. Serum was collected at each immunization and first colostrum was collected after parturition; all were assayed for Cryptosporidium-specific antibodies (Ab). A serological response to C. parvum sporozoite and oocyst antigen was detected in cows immunized with pCP15/60 plasmid DNA. Colostrum from these cows, unlike colostrum from normal controls, contained Ab specific for C. parvum sporozoites and oocysts as indicated by immunofluorescence Ab (IFA) staining. Colostrum was also tested for conferring passive immunity against C. parvum infection by oral administration to immunosuppressed adult inbred mice. Immune colostrum and control colostrum were administered to separate groups of dexamethasone (DEX)-treated adult C57BL/6NCr mice beginning 12 h before and at 12 h intervals for 3 days after oral C. parvum oocyst infection. Cryptosporidium development was assayed in ilea of immune- and control-colostrum-treated mice 96 h postinfection by semiquantitative PCR. Mice receiving immune colostrum showed partial protection (about 50% reduction) against intestinal C. parvum development compared to mice receiving control colostrum. This protection was evident at a challenge dose of 10(3) C. parvum oocysts per mouse; no differences were noted in parasite development between groups receiving immune or control colostrum and infected with 10(4) oocysts. This study showed that serum and colostrum Ab response to C. parvum can be elicited in preparturient cows by direct injection of recombinant pCP15/60 plasmid DNA and that passive protection against cryptosporidiosis can be obtained by treating immunosuppressed mice with immune colostrum before and after C. parvum infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392628     DOI: 10.1016/s0264-410x(98)00369-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Veterinary nutraceutical medicine.

Authors:  C Taillon; A Andreasen
Journal:  Can Vet J       Date:  2000-03       Impact factor: 1.008

2.  Comments regarding the claimed effectiveness of bovine colostrum.

Authors:  S Weese
Journal:  Can Vet J       Date:  2000-06       Impact factor: 1.008

Review 3.  Mammary gland immunity and mastitis susceptibility.

Authors:  Lorraine M Sordillo; Katie L Streicher
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 4.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

5.  Obtaining hyperimmune anti-Cryptosporidium parvum ovine colostrum. A study of the humoral immune response in immunized sheep.

Authors:  S Martín-Gómez; M A Alvarez-Sánchez; F A Rojo-Vázquez
Journal:  Parasitol Res       Date:  2005-11-16       Impact factor: 2.289

6.  Parasites and immunotherapy: with or against?

Authors:  Hossein Yousofi Darani; Morteza Yousefi; Marzieh Safari; Rasool Jafari
Journal:  J Parasit Dis       Date:  2014-08-31

7.  Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products.

Authors:  W B Strong; J Gut; R G Nelson
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

8.  Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.

Authors:  Michael W Riggs; Deborah A Schaefer; Sushila J Kapil; Lise Barley-Maloney; Lance E Perryman
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

9.  Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis.

Authors:  A F Kolb; L Pewe; J Webster; S Perlman; C B Whitelaw; S G Siddell
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  Breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in Bangladeshi infants: a prospective cohort study.

Authors:  Poonum S Korpe; Yue Liu; Abdullah Siddique; Mamun Kabir; Katherine Ralston; Jennie Z Ma; Rashidul Haque; William A Petri
Journal:  Clin Infect Dis       Date:  2012-12-12       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.